Abstract:Background and purpose:Tamoxifen(TAM),the pioneering selective estrogen receptor modulator(SERM),which blocks estrogen action by binding to the ER in breast cancers,has been used ubiquitously for endocrine therapy for the hormone-sensitive breast cancer.Intrinsic and acquired resistance to TAM limits the clinical use of TAM to a narrow therapeutic window and they are big challenges to the drug therapy for breast cancer patients.Better understanding of the TAM resistant mechanisms is therefore of considerable clinical significance.In our study,we induced breast cancer cell MCF-7 resistant to TAM in vitro and tried to explore the changes of autophagic levels and the expression of ERK(extracellular signal-regulated kinase,one of MAPK family proteins) and Phospho-ERK1/2 in TAM resistant cells compared with MCF-7 cells.Methods:Stepwise TAM selection was used to establish the TAM resistant TR5 subline.Autophagic vacuoles in cells were observed by means of transmission electron microscopy.The growth of the two cell lines were measured by CCK8,and the expression of LC3 Ⅱ,ERK1/2 and Phospho-ERK1/2 were measured by Western blot.Results:The TAM resistant cell line TR5 we established can be resistant to 5 μmol/L TAM.The number of autophagic vacuoles and the expression of LC3 Ⅱ protein in TR5 were obviously higher than that in MCF-7.There was no significant difference in the protein expression level of ERK1/2 between MCF-7 and TR5 cells,but the level of Phospho-ERK1/2 was markedly higher in TR5 cells than that in MCF-7 cells.Conclusion:TAM resistant MCF-7 cells have relatively high autophagic level and MAPK pathway is involved in facilitating TAM resistance.

Studies on Resistant Induction of Breast Cancer Cell MCF-7 to Tamoxifen in Vitro